← back to search

Carmon Kee

Heidelberg University · DE
Area of research
Infectious Diseases · Molecular Biology
Research interest
Research interests include SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, Genomics and Phylogenetic Studies, and Indoor Air Quality and Microbial Exposure.
h-index
13
citations
1,362
works
30
NIH funding
primary concept
email

Recent publications

Increased Sensitivity of SARS-CoV-2 to Type III Interferon in Human Intestinal Epithelial Cells
Journal of Virology 2022cited by 32position: middledoi
Single‐cell analyses reveal SARS‐CoV‐2 interference with intrinsic immune response in the human gut
Molecular Systems Biology 2021cited by 118position: middledoi
Single‐cell transcriptomics reveals immune response of intestinal cell types to viral infection
Molecular Systems Biology 2021cited by 57position: middledoi
SARS‐CoV‐2 infection remodels the host protein thermal stability landscape
Molecular Systems Biology 2021cited by 37position: middledoi
The endogenous cellular protease inhibitor SPINT2 controls SARS-CoV-2 viral infection and is associated to disease severity
PLoS Pathogens 2021cited by 8position: middledoi
Increased sensitivity of SARS-CoV-2 to type III interferon in human intestinal epithelial cells
bioRxiv (Cold Spring Harbor Laboratory) 2021cited by 0position: firstdoi
Critical Role of Type III Interferon in Controlling SARS-CoV-2 Infection in Human Intestinal Epithelial Cells
Cell Reports 2020cited by 357position: middledoi
Interferons and viruses induce a novel truncated ACE2 isoform and not the full-length SARS-CoV-2 receptor
Nature Genetics 2020cited by 267position: middledoi
Critical role of type III interferon in controlling SARS-CoV-2 infection, replication and spread in primary human intestinal epithelial cells
bioRxiv (Cold Spring Harbor Laboratory) 2020cited by 43position: middledoi
Interferons and viruses induce a novel primate-specific isoform dACE2 and not the SARS-CoV-2 receptor ACE2
bioRxiv (Cold Spring Harbor Laboratory) 2020cited by 25position: middledoi
Single-cell analyses reveal SARS-CoV-2 interference with intrinsic immune response in the human gut
bioRxiv (Cold Spring Harbor Laboratory) 2020cited by 15position: middledoi
Single-cell transcriptomics reveals immune response of intestinal cell types to viral infection
bioRxiv (Cold Spring Harbor Laboratory) 2020cited by 8position: middledoi
SPINT2 controls SARS-CoV-2 viral infection and is associated to disease severity
bioRxiv (Cold Spring Harbor Laboratory) 2020cited by 0position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Steeve Boulant · University of Florida13 papers (2020–2022)Megan L. Stanifer · University of Florida12 papers (2020–2022)Sergio Triana · Broad Institute6 papers (2020–2021)Theodore Alexandrov · BioInnovation Institute6 papers (2020–2021)Patricio Doldan · Queen Mary University of London5 papers (2020–2022)Markus Mukenhirn · University of Cambridge4 papers (2020–2021)Carl Herrmann · Centre for Innovation in Regulatory Science4 papers (2020–2021)Camila Metz‐Zumaran · German Cancer Research Center4 papers (2021–2022)Mohammed Shahraz · European Bioinformatics Institute4 papers (2020–2021)Ashwini Kumar Sharma · Age UK3 papers (2020–2021)Carlos Ramírez · Yale Cancer Center2 papers (2020–2021) · 2 papers (2020–2021)H.-G. Kraeusslich · Heidelberg University2 papers (2020–2020)Mirko Cortese · University of Campania "Luigi Vanvitelli"2 papers (2020–2020) · 2 papers (2020–2020)Abdul Rouf Banday · University of Connecticut2 papers (2020–2020)Diana Ordoñez‐Rueda · German Cancer Research Center2 papers (2020–2021)L. A. Thomas · University Hospital Heidelberg2 papers (2020–2021)Cuncai Guo · Heidelberg University2 papers (2021–2022)Lars M. Steinmetz · European Molecular Biology Laboratory2 papers (2020–2021)